Bernard A. Fox, Co – founder, President, and CEO of UbiVac, shared a post on LinkedIn:
“Leaving Logan Airport outside Boston and headed home to Portland! What a great 4 days. Agenus , Kelonia Therapeutics, and the IO360Summit!
Hats off to James Gulley, Axel Hoos for their work organizing the program! Also, congrats to Kate Woda and her team on a spectacularly well organized and run conference..
While flying home I am going to write another post or two about some of what I got out of this very unique meeting. As a proud member of the following 4 societies – let me say IO360 fills a gap and It is different than AACR, SITC, ASCO, ESMO – It is small, less than 500 attendees, and you can find, connect, and speak with any of the speakers.
In addition to the speakers in attendance was a spectrum of CSO and CEOs mingling with leading academics, senior BD folks from large Pharma, investment bankers, and biotech/pharma analysts.. Overall a great meeting for building bridges and figuring out how to move science and possible cures into patients Faster!”
Proceed to the video attached to the post.
Other articles featuring Bernard A. Fox on OncoDaily.